About Genome Compiler Corporation
Genome Compiler Corporation is a company based in Tel Aviv (Israel) founded in 2011 by Omri Amirav-Drory was acquired by Twist Bioscience in April 2016. Genome Compiler Corporation has raised $5 million across 4 funding rounds from investors including Autodesk, Twist Bioscience and NFX. Genome Compiler Corporation offers products and services including Alternative Link Service. Genome Compiler Corporation operates in a competitive market with competitors including Helix, Benchling, BioAge Labs, Ingenuity Systems and Genuity Science, among others.
- Headquarter Tel Aviv, Israel
- Founders Omri Amirav-Drory
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5 M (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
Autodesk
& 3 more
-
Employee Count
Not available
-
Acquired by
Twist Bioscience
(Apr 06, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genome Compiler Corporation
Genome Compiler Corporation offers a comprehensive portfolio of products and services, including Alternative Link Service.
Provides secure links for online registration and login
People of Genome Compiler Corporation
Unlock access to complete
Unlock access to complete
Software Development Team
76 people
Senior Team
45 people
Sales and Marketing
33 people
Product Management Team
22 people
Leadership Team
21 people
Staff Team
8 people
Research Team
7 people
Data Analysis and Operations Team
7 people
Unlock access to complete
Funding Insights of Genome Compiler Corporation
Genome Compiler Corporation has successfully raised a total of $5M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Genome Compiler Corporation
Genome Compiler Corporation has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Autodesk, Twist Bioscience and NFX.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm offering funding and tools for startups in technology and investment sectors.
|
Locked | Locked | Locked | |
|
Provider of cloud-based 3D CAD modeling software for the AEC industry
|
Locked | Locked | Locked | |
|
Delivers comprehensive e-commerce support services to businesses.
|
Locked | Locked | Locked |
Investor details for Genome Compiler Corporation
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genome Compiler Corporation
Investment portfolio details for Genome Compiler Corporation
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Genome Compiler Corporation
Detailed financials for Genome Compiler Corporation
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genome Compiler Corporation Comparisons
Peer comparison for Genome Compiler Corporation
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genome Compiler Corporation
Genome Compiler Corporation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, BioAge Labs, Ingenuity Systems and Genuity Science, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
|
| Locked | Locked | Locked |
Provider of bio informatics platform to develops biologics and therapeutics
|
Detailed competitors of Genome Compiler Corporation
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genome Compiler Corporation
Complete news archive for Genome Compiler Corporation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genome Compiler Corporation
Genome Compiler Corporation was founded in 2011.
Genome Compiler Corporation is headquartered in Tel Aviv, Israel.
Omri Amirav-Drory is the current CEO of Genome Compiler Corporation. They have also founded this company.
Genome Compiler Corporation is a funded company, having raised a total of $5M across 4 funding rounds to date.
A software platform is offered by Genome Compiler Corporation to support genetic engineers and synthetic biologists in DNA design, visualization, data management, and collaboration. Tools for plasmids and parts repositories, connections to DNA synthesis providers, and lab automation services are included to facilitate combinatorial project designs. The company was founded in 2011 and operates from locations in Tel Aviv, Israel, and Los Altos, California.
Genome Compiler Corporation's top competitors include Helix, Benchling and BioAge Labs.
Genome Compiler Corporation offers Alternative Link Service.
Genome Compiler Corporation has 4 investors. Key investors include Autodesk, Twist Bioscience, NFX, and Westcott.